LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives

Coronary artery diseases (CAD) inflict a heavy economical and social burden on most populations and contribute significantly to their morbidity and mortality rates. Low-density lipoprotein receptor (LDLR) associated familial hypercholesterolemia (FH) is the most frequent Mendelian disorder and is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Allaf, Faisal A, Coutelle, Charles, Waddington, Simon N, David, Anna L, Harbottle, Richard, Themis, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016243/
https://www.ncbi.nlm.nih.gov/pubmed/21144047
http://dx.doi.org/10.1186/1755-7682-3-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016243/
https://www.ncbi.nlm.nih.gov/pubmed/21144047
http://dx.doi.org/10.1186/1755-7682-3-36

Ejemplares similares